AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2014
Nov 6, 2014
32566_dirs_2014-11-06_2455df25-7cad-4841-9df8-babd16b71afe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2014-11-05
Reporting Person: LANCHBURY JERRY S (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-11-05 | Common Stock | M | 4328.0 | $23.11 | Acquired | 18879 | Direct |
| 2014-11-05 | Common Stock | M | 1.0 | $16.53 | Acquired | 18880 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-11-05 | Incentive Stock Option (right to buy) | $16.53 | M | 1.0 | Disposed | 2020-09-15 | Common Stock (1) | Direct |
| 2014-11-05 | Incentive Stock Option (right to buy) | $23.11 | M | 4328.0 | Disposed | 2020-03-03 | Common Stock (4328) | Direct |
Footnotes
F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2